The COVID-19 pandemic is holding the world, the economy and our health in a tight grip. So far Biontech/Pfizer have been successful with their vaccination, but as the virus mutates, it is unclear how effective the vaccination is. Many COVID-19 infected patients have to be hospitalized with a need for mechanical ventilation and that is where Humanigen plays a major role.
Humanigen reports positive Phase 3 topline results demonstrating that their drug under the name Lenzilumab™ improves survival without need for mechanical ventilation. These news are really huge and better yet: Humanigen has requested an Emergency-Use-Authorization (EUA) from the FDA.
Now looking at the price development of the share, there were some nice intraday profit taking (PT) opportunities, but the stock has actually a potential to grow much more.
Look at the trading range and monthly levels to set your PT levels. There was a nice retest of the support level (at 15$ and a bit below), which had provided and excellent opportunity to buy in cheap, but catching a falling knife takes a lot of practice (I rarely succeed myself, but I was lucky with this particular trade).
Have your PT goal in mind, because most of the times people lose money, because they become to greedy or don't cut losses (had to learn this the hard way myself :D).
Other than that, I am really optimistic on the upwards potential of this gem.
- This is no financial advice, so trade with care -
For transparency: I am invested in $HGEN with 1/3 of my stock portfolio and usually keep 2/3 for dollar cost averaging.
Humanigen reports positive Phase 3 topline results demonstrating that their drug under the name Lenzilumab™ improves survival without need for mechanical ventilation. These news are really huge and better yet: Humanigen has requested an Emergency-Use-Authorization (EUA) from the FDA.
Now looking at the price development of the share, there were some nice intraday profit taking (PT) opportunities, but the stock has actually a potential to grow much more.
Look at the trading range and monthly levels to set your PT levels. There was a nice retest of the support level (at 15$ and a bit below), which had provided and excellent opportunity to buy in cheap, but catching a falling knife takes a lot of practice (I rarely succeed myself, but I was lucky with this particular trade).
Have your PT goal in mind, because most of the times people lose money, because they become to greedy or don't cut losses (had to learn this the hard way myself :D).
Other than that, I am really optimistic on the upwards potential of this gem.
- This is no financial advice, so trade with care -
For transparency: I am invested in $HGEN with 1/3 of my stock portfolio and usually keep 2/3 for dollar cost averaging.
As you can see, the price is currently testing a monthly resistance around 18.40$USD (white thick line) - most likely I expect the upwards trend to continue and I am waiting for a bigger move, when Humanigen receives the EUA from the FDA. I suppose it will be more a matter of "when", rather than "if", since Lenzilumab has proven efficacy and Covid-19 is raging.
-This is no financial advice-